It took much longer for secondary hemostasis to stabilize, whereas platelet parameters were stable early in life.

Patients with recurrent bleeding were treated by the same modality as at randomization and secondary hemostasis was achieved in all.

Furthermore, the activated platelet surface provides an efficient catalytic surface for the coagulation reactions, ultimately resulting in the formation of fibrin ( secondary hemostasis).